What Is Propofol Amneal 200 mg/20 ml Indications and Uses?

Propofol Amneal 200 mg/20 ml (Propofol) Amneal is indicated in- Induction and maintenance of general anaesthesia. Sedation during intensive care. Sedation for surgical and diagnostic procedures.

Pharmacology (Source, Chemical and Physical Composition) Of Propofol Amneal 200 mg/20 ml

Propofol Amneal 200 mg/20 ml (Propofol) is a sedative-hypnotic agent for use in the induction and maintenance of anesthesia or sedation. Intravenous injection of a therapeutic dose of propofol produces hypnosis rapidly with minimal excitation, usually within 45 seconds from the start of an injection (the time for one arm-brain circulation). The action of propofol involves a positive modulation of the inhibitory function of the neurotransmitter gama-aminobutyric acid (GABA) through GABA-A receptors. Propofol is a highly lipid soluble, short-acting intravenous general anesthetic. Onset of general anesthesia occurs in most patients within 15-45 seconds. Most patients return to consciousness rapidly and recover without confusion or nausea. They are usually completely orientated within only a few minutes from recovery, and fit for discharge after only a few hours. Contrary to many other anesthetic agents, Propofol is not clinically significantly accumulated during maintenance dosage. It is therefore most suitable for sedation during intensive care. Propofol sets standards that inspire imitators. The clinical benefits of MCT/LCT are Superior to conventional LCT or MCT emulsions. Through Propofol- Technology, there is 30% less free, lipophilic and low-water soluble drug substance that can cause pain on injection compared to products dissolved in water, e.g., for Propofol। Remains the only formulation proven to reduce pain on injection site.

Drug Interactions of Propofol Amneal 200 mg/20 ml

Propofol Amneal 200 mg/20 ml (Propofol) Amneal has been used in association with spinal and epidural anaesthesia as well as with various types of premedicants, muscle relaxants, inhalation anaesthetics and analgetics. No pharmacological incompatibility has been observed. Lower doses of Propofol Amneal Amneal may be sufficient in case Propofol Amneal Amneal is used as an adjunct to local anaesthetic techniques. In doses applied clinically, Propofol Amneal Amneal will not inhibit the synthesis of adrenocortical hormones. Simultaneous administration of opiates may potentiate respiratory depression caused by Propofol Amneal Amneal.

Side Effects of Propofol Amneal 200 mg/20 ml

Local : Propofol Amneal 200 mg/20 ml (Propofol) Amneal is normally well tolerated. Its most common undesirable effect is pain at the site of injection that can be reduced by mixing the preparation with lidocaine or by injecting it into one of the larger veins of the forearm or the intercubital fossa. Thrombosis and phlebitis are rare. General : Hypotension and transient apnea may occur at the induction of anaesthesia, and may be severe especially in patients who are in a poor general condition. Epileptic movement, convulsions and dystonic reactions have been seen in rare cases. Pulmonary oedema has also been reported. Headache, nausea and, more rarely, vomiting may occur in some patients during recovery. Recovery may also be associated with another short period of impaired consciousness. Hypersensitivity has been reported in some cases, connected with anaphylactic symptoms such as marked hypotension, bronchospasm, oedema and facial erythema. Some cases of cardiac arrest have occurred in connection with the administration of Propofol Amneal Amneal. In connection with long-term administration of Propofol Amneal Amneal, green or reddish brown discolouration of urine may occur. This is caused by the quinol metabolites of Propofol Amneal Amneal, and is not dangerous. As with other anaesthetics, altered sexual behaviour may occur.

Precautions And Warnings for Propofol Amneal 200 mg/20 ml

Propofol Amneal 200 mg/20 ml (Propofol) Amneal should only be given by specialists in anaesthesiology or under their supervision. The physician performing a surgical or diagnostic procedure should not administer Propofol Amneal Amneal. Facilities for resuscitation in case of any complication should be available at the treatment unit. During the administration of Propofol Amneal Amneal, patients shall be monitored continuously to observe possible hypotension, obstruction in the respiratory tract, hypoventilation or insufficient oxygen intake at a sufficiently early stage. Special attention shall be paid to patients sedated by Propofol Amneal Amneal for a surgical or diagnostic procedure, who are not artificially ventilated. Caution shall be taken in administering Propofol Amneal Amneal to patients with cardiac, respiratory, renal or hepatic insufficiency. Hypovolemic patients and those with poor general condition form another risk group. Since Propofol Amneal Amneal lacks vagolytic activity, bradycardia, even asystole, may occur. Intravenous administration of an anticholinergic agent before induction and during maintenance of anaesthesia should be considered, especially if Propofol Amneal Amneal is used in conjunction with other agents likely to cause bradycardia and in situations where vagal tone is likely to predominate. Since Propofol Amneal Amneal is a lipid emulsion, appropriate care should be applied in patients with severe disorders of fat metabolism such as pathological hyperlipidemia. If Propofol Amneal Amneal is administered to a patient for whom excessive fat intake may be risky, blood lipid values shall be monitored and Propofol Amneal Amneal dosage decreased if necessary. If the patient is receiving other paranteral lipid emulsions in addition to Propofol Amneal Amneal, the amount of lipid in Propofol Amneal Amneal (0.1 g/ ml) shall be taken into account, when calculating the total intake of fat. In epileptic patients, Propofol Amneal Amneal may lead to convulsions. The analgetic effect of Propofol Amneal Amneal as such is insufficient. Analgetics shall be used to ensure sufficient analgesia. Full recovery from general anaesthesia shall be confirmed prior to discharge. It shall be noted that the aftermath of general anaesthesia may impair the patient's ability to understand instructions given postoperatively.

Use During Pregnancy and Lactation

Due to insufficient experience, Propofol Amneal 200 mg/20 ml (Propofol) shall not be used during pregnancy. Propofol is rapidly distributed to the foetus and shall therefore not be used for obstetric anaesthesia. Safety to the neonate has not been established in cases, where propofol has been administered to lactating women.

Therapeutic Class

General (Intravenous) anesthetics

Storage Conditions of It

Propofol Amneal Amneal should be stored at a temperature not exceeding 25º C. It must not be frozen. Any unused solution shall be discarded. Pack Image: Propofol Amneal 200 mg/20 ml Emulsion for infusion Thanks for using MedEx! How would you rate your experience so far?